| Similar Articles |
|---|
 |
Outside
April 2007 |
To the Victor Peter Diamandis will pay you to save the planet.   |
Bio-IT World
February 2006 |
News Blast Hit-to-Lead... Whole Genome... Gleevec Resistance... |
The Motley Fool
October 27, 2010
Ralph Casale |
Companion Diagnostics in Cancer Drug Development Diagnostic companies partnering with drug developers can make for an attractive investment segment. |
BusinessWeek
November 20, 2008
Steve LeVine |
Can X Prizes Spur Innovation? Contests such as Peter Diamandis' X Prizes offer big purses for breakthrough ideas. But can prize money do more to stimulate innovation than existing incentives? |
HHMI Bulletin
Nov 2010 |
Fusion genes that drive solid tumors are a new target for cancer therapies The success of Gleevec and related drugs has inspired researchers to step up their hunt for the molecular defects underlying other cancers. |
Wired
August 2003
Jennifer Kahn |
The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine. |
AskMen.com
Jacob Franek |
New Cancer Therapies As cancer research explodes, the availability of new and innovative interventions is expanding almost daily. |
Entrepreneur
September 2006
Steve Cooper |
Eye on the Prize Are you trying to develop the next big thing? Enlist help from bright minds outside your company by throwing in a prize. |
Bio-IT World
August 13, 2003
Malorye Branca |
Targeting Tumors Next-generation cancer drugs will take aim with unprecedented certainty, but making them requires a new discovery and development paradigm. |
Fast Company
January 2006
Michael A. Prospero |
Fuel for Thought Philanthropist Peter Diamandis' $10 million X Prize proved that money can drive big ideas. Now he's looking for more of them in other fields, from nanotech to education. |
Pharmaceutical Executive
July 1, 2011
Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
Bio-IT World
February 2006
Kevin Davies |
The Cancer Genome Atlas Pilot Launches Researchers from the National Cancer Institute and the National Human Genome Research Institute announced the launch of a three-year, $100 million pilot program for the Human Cancer Genome Project. |
Popular Mechanics
April 25, 2008
Erik Sofge |
Inside the Forgotten X Prize--the One That Can Save Your Life An extensive look at the Archon X Prize in Genomics, the $10 million race for a cheap, disease-hunting gene sequencer that could land on your kitchen counter sooner than you think. |
Bio-IT World
August 13, 2002
Kevin Davies |
Curtailing the Cancerous Cell The highly touted drug Gleevec unleashed new hope in the battle against cancer. Now a group of new drugs, working on the same principle, are showing even greater promise in treating leukemia. |
Wired
June 2006
Adam Rogers |
The Challenger When Peter Diamandis gave the $10 million Ansari X Prize to the SpaceShipOne crew in 2004, he did more than build excitement about private space travel. |
Chemistry World
February 2011 |
My hero: The greatest influences of chemistry Nobel laureates Aaron Ciechanover, who won the 2004 Nobel prize in chemistry with Avram Hershko and Irwin Rose for the discovery of ubiquitin-mediated protein degradation, talks about Charles Darwin. |
Scientific American
February 6, 2006
Patrick DiJusto |
Winner Takes All New technology prizes are designed to spur innovation and challenge entrepreneurs to do something that outstrips the state-of-the-art in return for a sizable payoff. But is basic research being prized out of the market? |
Bio-IT World
April 2006
Kevin Davies |
Harvard Opens Breast Cancer Protein Library In a landmark for functional proteomics, researchers at Harvard Medical School have unveiled a publicly available library of proteins that are active in breast cancer tissue. The resource could help speed drug discovery efforts against the disease. |
AskMen.com
Jacob Franek |
Prostate Cancer Overview Everything you wanted to know and more about prostate cancer in this three-part prostate cancer guide. |
Chemistry World
June 3, 2015
Matthew Gunther |
Chemistry Nobel laureate Irwin Rose dies aged 88 Rose, along with Aaron Ciechanover and Avram Hershko, received the prize for discovering how cells break down and dispose of unwanted proteins. |
Bio-IT World
March 2006
Kevin Davies |
Church Inquiry Gets Personal Harvard Medical School geneticist George Church with his plan for the Personal Genome Project is a likely contender for the X Prize that will be awarded to the group or individual that most helps cross the $1,00 genome threshold. |
American Family Physician
November 15, 2006
Wolff & Wilson |
Putting Prevention into Practice Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. |
BusinessWeek
May 12, 2011
Robert Langreth |
Big Pharma Bets on a Novel Cancer Cure Research in epigenetics is booming. The payoff could be in the billions. |
American Family Physician
October 1, 2000 |
Genetic Testing for Breast Cancer Risk: What Does It Mean to Me? What causes breast cancer?... What genes can cause breast cancer to be inherited?... What clues in my family history might show I've inherited a risk of breast cancer?... Does everyone who has family members with breast cancer have these mutated genes?... What should I do?... |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
Chemistry World
July 2010
Hayley Birch |
Special Report: Health breakthroughs of the decade New discoveries have been made with cancer vaccines, genomics, statin drugs, allosteric modulators, and RNA interference during the last decade. |
Bio-IT World
April 16, 2004 |
Portraits in Proteomics Advances in identifying protein biomarkers are spurring new hope in cancer diagnostics, expediting detection and easing testing. |
BusinessWeek
May 23, 2005
Catherine Arnst |
If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer. |
Chemistry World
January 12, 2015
Emma Stoye |
Protein mutant libraries to probe diseases' genetic link quickly and cheaply Researchers in the US have developed a faster and less costly way to investigate the effects of genetic mutations on proteins, which should offer new insights into hereditary diseases. |
Wired
September 13, 2007
Spencer Reiss |
Google Offers $20 Million X Prize to Put Robot on Moon Google will award $20 million to the first private team to put a robot on the moon. |
Chemistry World
January 21, 2011
Jennifer Newton |
Early lung cancer diagnosis Patients with lung cancer have elevated levels of a specific protein in their blood that could be used as a biomarker for the disease, say scientists from South Korea. |
Chemistry World
November 26, 2012
Andrew Turley |
Solvay launches 300,000 euro chemistry prize The prize will 'reward a major scientific discovery that could shape tomorrow's chemistry and help human progress'. |
Salon.com
July 14, 2000
Arthur Allen |
The cancer study bombshell that wasn't Were the New York Times and the Washington Post writing about the same New England Journal of Medicine article? |
BusinessWeek
August 26, 2010
Tom Randall |
Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer. |
Popular Mechanics
September 21, 2007
Matt Sullivan |
Mourning DIY, Debunking Halo 3 Hype and More: Podcast A podcast that will teach you some high-tech basics, explain what's wrong with Halo 3, and discuss the Google Lunar X Prize. |
Chemistry World
November 22, 2013
Emily James |
100 million for cancer research centers Cancer Research UK has invested 100 million pounds in 15 innovative research centers, acquiring high level expertise to solve the latest challenges in cancer. |
The Motley Fool
February 2, 2010
Brian Orelli |
Shaking Up the Biotech Industry A judge will decide if genes are patentable or not. |
The Motley Fool
May 28, 2010
Brian Orelli |
This Drug Doesn't Work. But All Is Not Lost. Novartis cancer drug fails one trial, but there's still hope. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
Cancer: On Target Once More Over the past year or two, a handful of Phase III failures, including megablockbusters like Avastin and Sutent in trials for all kinds of common tumors, indicate that targeted therapy is generally a blunt instrument. |
Chemistry World
May 22, 2014
Philip Ball |
Is junk DNA all garbage? It would be hard to find a recent scientific study that has excited more controversy than that of the international collaboration Encode. They suggested that up to 80% of our DNA was functional. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
Fast Company
David Lumb |
Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period. |
Entrepreneur
November 2009
Joe Robinson |
Is it Really Innovation? Peter Diamandis talks about what innovation really is while Tim O'Reilly calls the I-word era "dead on arrival." |
Scientific American
March 2009
Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
American Family Physician
May 15, 2005 |
Early Prostate Cancer: What You Should Know A patient hand-out on the disease, who is at risk, diagnosis and treatment options. |
BusinessWeek
October 17, 2005
Catherine Arnst |
Breast-Cancer Screening: How to Choose Women have varying risk factors for breast cancer and face more test options. Here are some key considerations for making a suitable choice. |
Chemistry World
October 7, 2015
Matthew Gunther |
DNA repair research takes the 2015 chemistry Nobel The 2015 Nobel Prize in chemistry has been awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for unraveling how cells deal with DNA damage. |
Salon.com
June 20, 2000
Naomi Mendelsohn |
Choosing the knife Healthy women at high risk for breast cancer are choosing to have both breasts removed, even while doctors are advocating less invasive treatments for those who are already sick |
The Motley Fool
September 28, 2010
Brian Orelli |
Pfizer's Sutent Fails. Again! No surprise here. |
Bio-IT World
July 11, 2002
Kevin Davies |
Counting the Cost of Drug Discovery Much of the trouble ensnaring the drug industry is blamed on the exorbitant cost of drug discovery. Tangible proof that the bio-IT revolution will economize drug discovery is emerging, but there is still a long way to go. |
